Estimates Revisions DexCom, Inc. Deutsche Boerse AG
Stocks
DC4
US2521311074
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.10 EUR | +0.49% |
|
-7.78% | +8.03% |
| Jul. 21 | Dexcom Insider Sold Shares Worth $2,041,999, According to a Recent SEC Filing | MT |
| Jul. 16 | Truist Adjusts Price Target on DexCom to $87 From $80, Maintains Buy Rating | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
- Consensus DexCom, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
